Dr. Holly L. Hake-Harris, MD

Dr. Hake-Harris practices at South Bend Clinic SurgiCenter in South Bend, Indiana.

Dr. Hake-Harris' NPI, 1538159207, was assigned on October 25, 2005. Dr. Hake-Harris graduated from University of Iowa, RJ & L Carver College of Medicine in 1982. Dr. Hake-Harris holds Indiana license 01035334A.

Dr. Hake-Harris' primary practice is South Bend Clinic SurgiCenter, at 211 N Eddy St, South Bend, IN 46617. The practice phone is (574) 237-9366.

Dr. Hake-Harris' primary practice is South Bend Clinic SurgiCenter in South Bend, Indiana. The medical group on file is The South Bend Clinic. Dr. Hake-Harris' employer is on file too: a surgery center (asc).

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hake-Harris practices. Vendor and product names are available with a free account.

Dermatology is Dr. Hake-Harris' primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Hake-Harris is licensed in Indiana.

CMS data shows 3,593 Medicare services from Dr. Hake-Harris across 28 procedure codes in 2024, for 691 Medicare patients. Medicare paid $767,987 for them. Every service was in an office.

CMS counts 691 Medicare patients who saw Dr. Hake-Harris in 2024. The largest group is 75 to 84, with 288 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 2% are also on Medicaid. Their average risk score is 1.14, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Hake-Harris' median patient age at 77, with 50% women.

In 2024, Dr. Hake-Harris wrote 533 Medicare Part D claims for 314 patients. 97% of them were for generic drugs. CMS names the drug for 451 of them, across 9 drugs with 11 or more claims each, at $3,870 in total drug cost. In 2023, CMS named 417 claims across 8 drugs.

Dr. Hake-Harris accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 424 procedures of melanoma (skin cancer) excision by Dr. Hake-Harris, more than 99% of the clinicians it reports for that procedure.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links Dr. Hake-Harris to 9 clinical trials. Conditions studied include Eczema, Psoriasis and Dermatitis, Atopic. Eli Lilly and Company sponsors the most, 9. Open Payments lists research payments to Dr. Hake-Harris that name 10 trials.

CMS Open Payments shows 57 general payments to Dr. Hake-Harris from 15 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 67% of the total. Eli Lilly and Company paid the most, $3,830. It also lists 34 research payments totaling $538,715 from 2016 to 2025, naming 10 clinical trials.

Dr. Hake-Harris graduated from University of Iowa, RJ & L Carver College of Medicine in 1982.